Overview
NanoTemper Technologies provides high-precision biophysical characterization tools for biopharma discovery, development, and manufacturing, including instruments like Dianthus, Prometheus Panta C, and Andromeda X. These enable protein stability assessment, binding analysis, expression screening, and label-free single-molecule analysis via recent acquisitions and launches. Solutions support end-to-end workflows from early drug discovery to commercial production, with features for 21 CFR Part 11 compliance and low sample volumes.
Frequently asked questions
- What biophysical characterization capabilities does NanoTemper offer for drug discovery?
- NanoTemper offers tools like Dianthus with Spectral Shift, TRIC, Optical Unfolding for protein stability, and Slow Kinetics for long-lived interactions, plus NSM for single-molecule label-free analysis of proteins and nucleic acids.
- Does NanoTemper support regulatory compliance in pharma environments?
- Yes, Prometheus Panta C supports 21 CFR Part 11 compliance, data integrity, LIMS integration, and automated workflows for developability assessment and process monitoring in regulated settings.
- What are NanoTemper's global operations and support for biopharma?
- NanoTemper operates from locations including Munich (Germany), Gothenburg (Sweden), and South San Francisco (USA), serving biopharma and CROs across the value chain from discovery to manufacturing.